Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Camptothecin

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Camptothecin?

Camptothecin is an investigational drug.

There have been 93 clinical trials for Camptothecin. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 1998.

The most common disease conditions in clinical trials are Lung Neoplasms, Small Cell Lung Carcinoma, and Lymphoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Astex Pharmaceuticals, and University of New Mexico.

Recent Clinical Trials for Camptothecin
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel CancersNational Cancer Institute (NCI)Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel CancersSouthwest Oncology GroupPhase 2
FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic CancerNational Cancer Institute (NCI)Phase 2

See all Camptothecin clinical trials

Clinical Trial Summary for Camptothecin

Top disease conditions for Camptothecin
Top clinical trial sponsors for Camptothecin

See all Camptothecin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.